How a bacterial proteasome switch helps tuberculosis bacteria manage proteins

Mycobacterium tuberculosis, the bacterium that causes tuberculosis, relies on a protein quality control machine called the proteasome. A regulatory particle of that system, the bacterial proteasomal activator Bpa (Rv3780), recruits proteins and opens the gate of the proteasome 20S core particle to allow degradation. Despite this central role, the structural details of how Bpa assembles into its active form and how it recognizes substrates were unclear. In work led by Siavash Vahidi, researchers set out to define how Bpa oligomerizes and how it engages a substrate. Because many native substrates of Bpa are poorly soluble and difficult to study, the team also sought a tractable surrogate to observe substrate binding and degradation. Their experiments focused on whether Bpa forms different sized assemblies, how temperature influences those assemblies, and which parts of Bpa and a chosen substrate make contact during binding. The study combined biochemical and biophysical approaches to reveal a thermosensitive switch in Bpa assembly and to establish a workable model substrate for investigating proteasomal recognition in M. tuberculosis.

The team used a suite of complementary techniques to map Bpa behavior and interactions. Using size-exclusion chromatography and charge detection mass spectrometry, they showed that Bpa reversibly assembles into a dodecameric ring from dimeric and tetrameric species in a temperature-dependent manner. Pulsed hydrogen/deuterium exchange mass spectrometry (HDX-MS) was applied to map oligomerization interfaces during Bpa assembly. Methyl transverse relaxation optimized spectroscopy (TROSY)-based NMR experiments, together with site-specific truncations, validated the existence of discrete tetrameric and dodecameric states. To overcome poor solubility of native targets, the researchers established the DNA-binding domain of hTRF1 as a surrogate substrate. They demonstrated that Bpa binds hTRF1 and mediates its degradation in a 20S CP-dependent manner. With methyl-TROSY NMR they quantified the interaction, finding a stoichiometry of 12 Bpa subunits to 3 hTRF1 molecules and a micromolar affinity that is modulated by salt concentration. NMR mapping pinpointed interaction surfaces on both Bpa and hTRF1 and identified key hydrophobic residues that mediate substrate engagement.

These results reveal a thermosensitive switch that regulates Bpa oligomerization and activity, offering a clearer picture of how a bacterial proteasome activator assembles and recognizes cargo. By defining the transition between dimer, tetramer, and dodecamer and locating the contact patches involved in substrate binding, the study provides structural and mechanistic footholds for further investigation. The introduction of hTRF1 as a tractable surrogate substrate solves a practical obstacle to studying Bpa function and opens the door to more detailed studies of proteasomal recognition in M. tuberculosis. Taken together, the findings supply a framework that other researchers can use to dissect how bacterial proteasomes select and process proteins, and they provide precise targets—specific oligomeric states and hydrophobic residues—that can be examined in future structural, biochemical, or inhibitor-development work aimed at the mycobacterial proteasome system.